Results 301 to 310 of about 1,109,482 (395)

Changes in Bone Microarchitecture and Inflammatory Cytokines After Cure of Chronic Hepatitis C Infection With Direct-Acting Antiviral Therapy. [PDF]

Open Forum Infect Dis
Lo Re V, Carbonari DM, Newcomb CW, Torgersen J, Weinstein EJ, Smith SM, Brecker KL, Liu XS, Kostman JR, Trooskin S, Hubbard RA, Baker JF, Zemel BS, Leonard MB.   +13 more
europepmc   +1 more source

Health Disparities in Achieving Sustained Virologic Response Among Patients With Chronic Hepatitis C: A Retrospective Single-Center Study. [PDF]

Cureus
Leach E, Rana R, Nguyen C, Reinecke J, Hall A, Velagapudi M.   +5 more
europepmc   +1 more source

The Intersection Of Chronic Hepatitis C Infection And Cardiovascular Disease

, 2017
Kimberly Autumn Forde-Mclean
openalex   +1 more source

Albumin-bilirubin score reflects the extent of liver fibrosis in chronic hepatitis C patients treated with direct-acting antivirals. [PDF]

World J Hepatol
Ewid M, Sherif H, Saquib N, Alammari AM, Ismail AAM, Alkahlot MH, Ahmed ZT, Al-Zabidi FZM, Al Mutiri N.   +8 more
europepmc   +1 more source

Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C Infection Treated with Direct-Acting Antivirals: A Systematic Review and Meta-Analysis. [PDF]

Infect Dis Ther
Lindsley K, Burroughs M, Hernandez-Lopez C, Wang Y, Marcinak J, Chiuve SE, Haber BA, Uyei J, Navadeh S, De Marco G, Hill DD.   +10 more
europepmc   +1 more source

Changes in Three-Dimensional Volumetric Liver Fat Fraction after Cure of Chronic Hepatitis C Infection with Direct-Acting Antivirals

Jessie Torgersen, Craig Newcomb, Dean M Carbonari, Shanae M Smith, Katherine L Brecker, Chamith S. Rajapakse, Brandon C. Jones, Christiana Cottrell, Rasleen Grewal, Jennifer C Price, Joshua F Baker, Jay R. Kostman, Stacey Trooskin, Rebecca A Hubbard, B. Zemel, Mary B. Leonard, Vincent Lo Re   +16 more
openalex   +1 more source

Cancer risks and trends between 1997 and 2018, and effects of restored immunity in people living with HIV: Results from the ANRS CO4 French hospital database on HIV

International Journal of Cancer, EarlyView.
What's New? This large nation‐wide cohort study provides a comprehensive 20‐year analysis of cancer trends among people living with HIV in France, highlighting persistent excess risks for virus‐related cancers despite effective antiretroviral therapy and immune restoration.
Sophie Grabar, Paula Lakrout, Valérie Potard, Aurélien Belot, Jacques Cadranel, Christine Jacomet, Christine Katlama, Esaïe Marshall, Olivier Lambotte, Romain Palich, Sylvie Ronot‐Bregigeon, Jean‐Philippe Spano, Anne‐Marie Bouvier, Alain Makinson, Dominique Costagliola   +14 more
wiley   +1 more source

lncRNAs as Biomarkers of Hepatocellular Carcinoma Risk and Liver Damage in Advanced Chronic Hepatitis C. [PDF]

Curr Issues Mol Biol
Dos Santos DB, Fernandez GJ, Silva LT, Silva GF, Lima EO, Galvani AF, Pereira GL, Ferrasi AC.   +7 more
europepmc   +1 more source

Five‐year outcomes of pembrolizumab versus chemotherapy in Chinese patients with non‐small‐cell lung cancer and programmed cell death ligand 1 tumor proportion score ≥1%: KEYNOTE‐042 China study

International Journal of Cancer, EarlyView.
What's New? Global research has found that for people newly diagnosed with advanced non‐small cell lung cancer (NSCLC), the anti‐PD‐1 monoclonal antibody pembrolizumab on its own often leads to better results than traditional chemotherapy. The present report details long‐term findings of pembrolizumab therapy specifically among Chinese patients.
Yi‐Long Wu, Li Zhang, Yun Fan, JianYing Zhou, Li Zhang, Qing Zhou, Wei Li, ChengPing Hu, GongYan Chen, Xin Zhang, CaiCun Zhou, Carmen González Arenas, Zhenghong Chen, Wen Cheng Yu, Tony S. K. Mok   +14 more
wiley   +1 more source

Effectiveness and Safety of Glecaprevir/Pibrentasvir Combination Therapy in Patients Diagnosed with Chronic Hepatitis C. [PDF]

J Clin Pract Res
Karabulut K, Aygen B, Yıldız O, Kahveci HN, Ture Z, Ünüvar GK, Karabulut AY.   +6 more
europepmc   +1 more source